SS Innovations International (SSII) Change in Accured Expenses (2016 - 2026)
SS Innovations International (SSII) reported Change in Accured Expenses of $256441.0 for Q1 2026, up 430.59% on a YoY basis from $48331.0 in Q1 2025, and up 21.54% sequentially from $210997.0 in Q4 2025.
SS Innovations International (SSII) Change in Accured Expenses (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Change in Accured Expenses data on file, last reported at $256441.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 430.59% year-over-year to $256441.0; the trailing twelve-month figure through Mar 2026 stood at $370024.0 (down 24.01% YoY), and the FY2025 full-year result was $161914.0, down 85.85% from the prior year.
- Change in Accured Expenses rose to $256441.0 in Q1 2026, from $210997.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q2 2025 to a low of -$1.7 million in Q3 2025.
- A 5-year average of $129458.4 and a median of $158047.0 in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses surged 2126.29% in 2023 and plunged 488.05% in 2025, its largest moves.
- Tracing SSII's Change in Accured Expenses over 5 years: stood at $133082.0 in 2022, then soared by 74.19% to $231810.0 in 2023, then sank by 141.96% to -$97261.0 in 2024, then jumped by 316.94% to $210997.0 in 2025, then grew by 21.54% to $256441.0 in 2026.
- Business Quant data shows SSII's Change in Accured Expenses at $256441.0 in Q1 2026, $210997.0 in Q4 2025, and -$1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 21.07 Mn |
| 10 | SS Innovations International | 666.70 Mn | 643.09 Mn | 5.33 Mn | 256,441.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256,441.00 |
| Mar 31, 2026 | 256,441.00 |
| Dec 31, 2025 | 210,997.00 |
| Dec 31, 2025 | 210,997.00 |
| Sep 30, 2025 | -1.68 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 48,331.00 |
| Mar 31, 2025 | 48,331.00 |
| Dec 31, 2024 | -97,261.00 |
| Dec 31, 2024 | -97,261.00 |
| Sep 30, 2024 | 432,480.00 |
| Sep 30, 2024 | 432,480.00 |
| Jun 30, 2024 | 103,363.00 |
| Jun 30, 2024 | 103,363.00 |
| Mar 31, 2024 | 705,455.00 |
| Mar 31, 2024 | 705,455.00 |
| Dec 31, 2023 | 231,810.00 |
| Dec 31, 2023 | 231,810.00 |